Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Cervarix proves 90% effective at cervical cancer
Posted Jun 28th 2007 2:23PM by Brian White
Filed under: Cervical Cancer
Cervarix, an experimental cervical cancer vaccine made by British pharmaceutical firm GlaxoSmithKline, had somewhat of an important public milestone this week, as The Lancet published information on the vaccine being 90 percent effective in preventing precancerous cervical lesions.
These results do indeed
confirm previous data on the effectiveness of Cervarix, and as such, the stage is set for the vaccine to become a big hit with cervical cancer sufferers and women who have just been diagnosed.
Australia has already approved Cervarix, and expected approval for Europe is slated to happen this year in the second half. For a U.S. release, we'll have to wait until sometime in 2008. That is, if is is approved here.
Tags: Cervarix, Cervical cancer, CervicalCancer
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
